Searched for
RISING INSULIN PRICES
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- Govt cracks down on GLP-1 drugs: Safety first amid weight-loss hypeIndia's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are now prescriptio...
- Novo Nordisk bets on cheaper Ozempic to dominate India’s booming weight-loss marketNovo Nordisk has launched Ozempic in India at a competitive price, aiming to capture a significant share of the growing weight-loss market....
- This surprising diet helps Type 1 Diabetes patients slash their insulin useA new study suggests a low-fat vegan diet can significantly reduce insulin needs for type 1 diabetes patients. This dietary change may also...
- Domestic drug companies in a sweet spot as global players look beyond insulinIndian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations. Affordable insulin...
- Here's Bill Clinton's solution on how Kamala Harris can take down Donald Trump in U.S electionsAs the US Presidential Elections approaches close with every passing day, both the Presidential candidates are intensifying their campaign ...
- Eli Lilly impersonator reveals identity after drug company's stocks fall with his fake tweetThe person whose tweet about ‘Insulin is free’ from a parody account of Eli Lilly goes public by sharing a video. The tweet caused the stoc...
- Most of House Republicans in US vote against capping price of insulinThe US House of Representatives has passed a bill popularly known as the Insulin Price Bill that limits insulin costs to $35 per month. The...
- Reduce Biocon, target price Rs 250: EdelweissThe stock is trading at 32 times FY22E EPS, which factors in the benefit from potential launches, but not the risks involved.
- Unable to afford insulin? This WHO initiative aims at helping diabetics by slashing pricesThere are currently more than 420 million diabetic adults in the world.
- Biocon shares hit 2-week high post Q3 numbersConsolidated total income from operations also increased to Rs 1,044.4 crore for the quarter under review as against Rs 807.1 crore in the ...
- Biocon sees build up of open interest, stock flatA rise in open interest along with a rise in the stock price is seen as a positive trend. But a rise in open interest along with flat stock...
- Pushing diabetics to take insulin is a medical scam: Fiona GodleeWith diabetes becoming such an epidemic in India, we need to look at the root causes and put money there rather than putting people on insu...
- Foreign drug cos can't raise prices arbitrarily, NPPA to cut profit marginIndia's drug price regulator will no longer allow foreign drug companies to arbitrarily increase prices of their imported medicines by mere...
- Wockhardt to raise insulin prices; stock downThe drug price regulator has allowed local pharma companies Wockhardt and Biocon to increase prices of their insulin brands due to rising i...
- Wockhardt, Biocon allowed to raise Insulin prices by 18%NPPA has slashed the price of anti-asthma bulk drug used in popular brands such as Cipla's Asthalin, by 18% to Rs 3,633 per kg.
- NPPA allows hike in insulin priceIndian drug price regulator has allowed local drugmakers such as Biocon and Wockhardt to increase the price of insulin used by diabetes pat...
- Lilly 1Q profit rises on higher sales, flat costsDrugmaker Eli Lilly & Co. said Monday its first-quarter profit rose 24 per cent on a boost in sales of the antidepressant Cymbalta and the ...
- NPPA revision of 174 drug prices may lead to costlier medicinesInsulin brands, steroids and painkillers may become more expensive once NPPA revises prices of more than 170 medicines, in some cases by as...
- Religare upholds 'Buy' on Biocon at Rs 542Religare Research has maintained a ‘buy’ on Biocon post its second quarter earnings for the September quarter. It has set a target price of...
Load More
